4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-26-046201
CEO CFO gave up 1,411,982 shares (to pay taxes)
- CEO CFO acquired 3,227,384 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO CFO | 2026-10-06 | Option exercise | +3,227,384 | 3,356,672 | D | ||
| Finley John David CEO CFO | 2026-10-06 | Shares withheld for taxes | −1,411,982 | $1.49 | $2,103,853 | 1,944,690 | D |
| Derivatives | |||||||
| Finley John David CEO CFO | 2026-10-06 | Option exercise · Restricted Stock Units | −3,059,800 | 6,119,600 | D | ||
| Finley John David CEO CFO | 2026-10-06 | Option exercise · Restricted Stock Units | −167,584 | 1,508,249 | D | ||
Loading xslF345X06/ownership.xml…